Recall D-0402-2026

US Class II Ongoing · initiated 2026-03-17

Recalling firm

Chiesi USA, Inc., NC

Product

CUROSURF (poractant alfa), 240 mg, Intratracheal Suspension, 3L Single-dose-Vial, Rx only, Chiesi USA, Inc, Cary, NC 27518, NDC 10122-510-03.

Reason for recall

Lack of Assurance of Sterility

← All recalls